Cargando…
A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted
Previous studies of SARS-CoV-2 viral infection suggest that both the humoral and cytotoxic arms of the immune system are weak in patients with severe COVID-19 disease when compared to mild disease. A cytokine storm is also induced in severe disease. IL-15 has been shown to support the cytotoxic arm...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583616/ https://www.ncbi.nlm.nih.gov/pubmed/33199178 http://dx.doi.org/10.1016/j.cytogfr.2020.10.005 |